Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Cardiology

Journal Scan / Research · October 08, 2014

Inhibition of PCSK9 With Evolocumab in Homozygous Familial Hypercholesterolemia

The Lancet

 

Additional Info

The Lancet
Inhibition of PCSK9 With Evolocumab in Homozygous Familial Hypercholesterolaemia (TESLA Part B): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 2014 Oct 01;[EPub Ahead of Print], FJ Raal, N Honarpour, DJ Blom, GK Hovingh, F Xu, R Scott, SM Wasserman, EA Stein

Further Reading